Vistagen Therapeutics (VTGN) Short Interest Ratio & Short Volume $2.50 +0.25 (+11.11%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Vistagen Therapeutics Short Interest DataVistagen Therapeutics (VTGN) has a short interest of 425,500 shares, representing 1.70% of the float (the number of shares available for trading by the public). This marks a -0.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 200,875 shares to cover all short positions.Current Short Interest425,500 sharesPrevious Short Interest427,500 sharesChange Vs. Previous Month-0.47%Dollar Volume Sold Short$1.21 millionShort Interest Ratio2.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares27,843,000 sharesFloat Size25,020,000 sharesShort Percent of Float1.70%Today's Trading Volume984,364 sharesAverage Trading Volume200,875 sharesToday's Volume Vs. Average490% Short Selling Vistagen Therapeutics? Sign up to receive the latest short interest report for Vistagen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTGN Short Interest Over TimeVTGN Days to Cover Over TimeVTGN Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Vistagen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024425,500 shares $1.21 million -0.5%1.7%2.1 $2.84 11/15/2024427,500 shares $1.12 million -19.1%1.7%2.3 $2.63 10/31/2024528,200 shares $1.63 million -18.1%2.1%3.3 $3.08 10/15/2024644,700 shares $1.88 million -5.2%2.7%4.7 $2.92 9/30/2024679,900 shares $2.05 million -7.9%2.8%5.7 $3.01 9/15/2024738,300 shares $2.43 million -6.7%3.0%6.8 $3.29 Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024791,300 shares $2.76 million -4.3%3.3%7.3 $3.49 8/15/2024826,700 shares $2.79 million +8.2%3.4%7.3 $3.38 7/31/2024764,100 shares $2.62 million -4.5%3.1%6.8 $3.43 7/15/2024799,800 shares $3.13 million -7.8%3.3%6.1 $3.91 6/30/2024867,600 shares $3.02 million -2.5%3.6%6.1 $3.48 6/15/2024889,500 shares $3.13 million -11.1%3.7%4.6 $3.52 5/31/20241,000,000 shares $3.86 million -5.7%4.1%4.9 $3.86 5/15/20241,060,000 shares $4.87 million -10.2%4.4%4.6 $4.59 4/30/20241,180,000 shares $5.70 million -8.5%4.9%4.6 $4.83 4/15/20241,290,000 shares $6.13 million +0.8%5.3%4.9 $4.75 3/31/20241,280,000 shares $6.76 million -3.8%5.3%4.4 $5.28 3/15/20241,330,000 shares $5.39 million -8.9%5.5%4.7 $4.05 2/29/20241,460,000 shares $7.46 million -15.1%6.0%3.6 $5.11 2/15/20241,720,000 shares $9.32 million +27.4%7.1%4.1 $5.42 1/31/20241,350,000 shares $6.45 million +16.4%5.6%2.6 $4.78 1/15/20241,160,000 shares $6.32 million -28.8%4.8%2.1 $5.45 12/31/20231,630,000 shares $8.38 million +37.0%6.7%2.7 $5.14 12/15/20231,190,000 shares $5.93 million -4.8%4.9%1.8 $4.98 11/30/20231,250,000 shares $4.49 million -21.4%5.1%2.1 $3.59 11/15/20231,590,000 shares $5.23 million +2.6%6.4%2.7 $3.29 10/31/20231,550,000 shares $4.93 million +14.8%7.0%1.4 $3.18 10/15/20231,350,000 shares $4.64 million +61.6%6.1%0.7 $3.44 9/30/2023835,300 shares $4.38 million +16.8%3.5%0.4 $5.24 9/15/2023715,100 shares $4.25 million -31.9%7.7%0.4 $5.95 8/31/20231,050,000 shares $5.60 million -18.0%11.3%0.6 $5.33 8/15/20231,280,000 shares $8.04 million +132.2%13.8%0.7 $6.28 7/31/2023551,300 shares $1.00 million +18.1%7.0%0.4 $1.82 7/15/2023467,000 shares $826,590.00 +36.3%6.0%2.3 $1.77 6/30/2023342,600 shares $640,662.00 -50.2%4.4%1.7 $1.87 6/15/2023687,500 shares $1.43 million +72.2%9.5%3.2 $2.08 5/31/2023399,200 shares $1.70 million -96.8%N/A2.3 $4.26 5/15/202312,450,000 shares $1.75 million -12.0%N/A3.6 $0.14 4/30/202314,150,000 shares $1.98 million -10.6%N/A3 $0.14 4/15/202315,820,000 shares $2.19 million +25.0%N/A2.9 $0.14Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 3/31/202312,660,000 shares $1.58 million +47.7%N/A2.1 $0.12 3/15/20238,570,000 shares $1.31 million +17.4%N/A1.2 $0.15 2/28/20237,300,000 shares $1.28 million -14.9%N/A1 $0.18 2/15/20238,580,000 shares $1.70 million -15.8%N/A1.1 $0.20 1/31/202310,190,000 shares $2.64 million -17.8%N/A1.5 $0.26 1/15/202312,400,000 shares $1.98 million -19.7%N/A2.1 $0.16 12/30/202215,440,000 shares $1.59 million +36.9%N/A2.5 $0.10 12/15/202211,280,000 shares $1.27 million +24.2%N/A2.1 $0.11 11/30/20229,080,000 shares $1.25 million -1.2%N/A1.7 $0.14 11/15/20229,190,000 shares $1.46 million +13.7%N/A1.5 $0.16 10/31/20228,080,000 shares $1.07 million +26.5%4.6%0.9 $0.13 10/15/20226,390,000 shares $713,124.00 +12.9%3.6%0.5 $0.11 9/30/20225,660,000 shares $860,886.00 +18.4%3.2%0.4 $0.15 9/15/20224,780,000 shares $916,326.00 -12.8%2.7%0.3 $0.19 8/31/20225,480,000 shares $1.01 million -13.3%3.1%0.4 $0.18 8/15/20226,320,000 shares $995,400.00 -30.1%4.1%0.5 $0.16 7/31/20229,040,000 shares $1.29 million -46.1%5.8%1.1 $0.14 7/15/202216,770,000 shares $13.08 million +16.1%10.8%3 $0.78 6/30/202214,440,000 shares $12.71 million +2.1%9.3%11.8 $0.88 6/15/202214,150,000 shares $13.35 million +30.7%8.8%10.7 $0.94 5/31/202210,830,000 shares $12.45 million +1.2%6.8%7.3 $1.15 5/15/202210,700,000 shares $12.20 million +0.1%6.7%7.2 $1.14 4/30/202210,690,000 shares $13.58 million +6.2%6.7%6.9 $1.27 4/15/202210,070,000 shares $16.31 million -2.4%6.3%6.3 $1.62 3/31/202210,320,000 shares $12.80 million -10.7%6.4%6.8 $1.24 3/15/202211,560,000 shares $13.18 million -2.3%7.2%8.3 $1.14 2/28/202211,830,000 shares $16.56 million +1.7%7.5%9.8 $1.40 2/15/202211,630,000 shares $18.61 million -0.5%7.3%9.3 $1.60 1/31/202211,690,000 shares $19.05 million +2.4%7.6%8.9 $1.63 1/15/202211,420,000 shares $19.87 million +2.2%7.4%9 $1.74 12/31/202111,170,000 shares $21.78 million +1.6%N/A9.1 $1.95 12/15/202110,990,000 shares $20.44 million +3.0%7.2%9.1 $1.86 11/30/202110,670,000 shares $20.59 million +3.3%7.0%8.8 $1.93 11/15/202110,330,000 shares $22.21 million -7.1%6.8%9 $2.15 10/29/202111,120,000 shares $25.46 million -4.6%7.7%10.4 $2.29 10/15/202111,650,000 shares $27.84 million -3.6%8.0%11.3 $2.39 9/30/202112,080,000 shares $33.10 million +29.5%8.3%11.1 $2.74 9/15/20219,330,000 shares $27.24 million -6.5%6.4%5.2 $2.92 8/31/20219,980,000 shares $30.34 million -8.4%6.9%5.2 $3.04 8/13/202110,890,000 shares $30.17 million -5.7%7.7%5.1 $2.77 7/30/202111,550,000 shares $30.72 million -1.4%7.9%4.2 $2.66 7/15/202111,710,000 shares $33.14 million -5.1%6.9%4 $2.83 6/30/202112,340,000 shares $38.87 million +88.7%7.3%4.2 $3.15 6/15/20216,540,000 shares $18.12 million -3.0%3.9%2.9 $2.77 5/28/20216,740,000 shares $17.46 million +2.9%4.0%3.1 $2.59 5/14/20216,550,000 shares $13.95 million +3.8%N/A2.8 $2.13 4/30/20216,310,000 shares $15.21 million +2.8%N/A2.1 $2.41 4/15/20216,140,000 shares $12.89 million -1.4%N/A1.9 $2.10 3/31/20216,230,000 shares $13.33 million -32.5%N/A1.8 $2.14 3/15/20219,230,000 shares $21.69 million +8.5%N/A2.1 $2.35Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 2/26/20218,510,000 shares $18.81 million +62.1%N/A2 $2.21 2/12/20215,250,000 shares $10.40 million -2.6%N/A1.3 $1.98 1/29/20215,390,000 shares $11.16 million +0.4%N/A2.1 $2.07 1/15/20215,370,000 shares $12.46 million +54.3%N/A2.3 $2.32 12/31/20203,480,000 shares $6.16 million +48.7%8.3%1.9 $1.77 12/15/20202,340,000 shares $1.75 million -18.5%N/A1.7 $0.75 11/30/20202,870,000 shares $2.21 million +2.9%N/A4.4 $0.77 10/30/20202,900,000 shares $2.18 million -9.4%N/A2.8 $0.75 10/15/20203,200,000 shares $2.44 million +27.5%N/A1.8 $0.76 9/30/20202,510,000 shares $1.75 million -17.7%N/A1.1 $0.70 9/15/20203,050,000 shares $1.99 million -9.0%N/A1.3 $0.65 8/31/20203,350,000 shares $2.35 million +3.1%N/A1.4 $0.70 8/14/20203,250,000 shares $2.46 million +2.9%N/A1.3 $0.76 7/31/20203,160,000 shares $2.94 million +97.5%N/A1.4 $0.93 7/15/20201,600,000 shares $863,200.00 -10.6%N/A1.1 $0.54 6/30/20201,790,000 shares $943,509.00 +45.5%N/A1.9 $0.53 6/15/20201,230,000 shares $661,002.00 -3.9%3.0%1.5 $0.54 5/29/20201,280,000 shares $565,248.00 -2.3%3.1%1.8 $0.44 5/15/20201,310,000 shares $481,949.00 +6.5%3.2%2.5 $0.37 4/30/20201,230,000 shares $529,269.00 -8.2%3.0%3.3 $0.43 4/15/20201,340,000 shares $644,406.00 -2.9%3.3%4.2 $0.48 3/31/20201,380,000 shares $607,200.00 -4.6%3.4%4.5 $0.44 3/13/20201,447,000 shares $665,620.00 +8.8%3.7%4.7 $0.46 2/28/20201,330,000 shares $465,500.00 -22.2%3.4%1.9 $0.35 2/14/20201,710,000 shares $940,500.00 -21.6%4.3%2.4 $0.55 1/31/20202,180,000 shares $1.31 million -17.4%5.6%2.6 $0.60 1/15/20202,640,000 shares $1.93 million -8.3%7.0%3.2 $0.73 12/31/20192,880,000 shares $2.30 million +15.2%7.6%3.4 $0.80 VTGN Short Interest - Frequently Asked Questions What is Vistagen Therapeutics' current short interest? Short interest is the volume of Vistagen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 425,500 shares of VTGN short. 1.70% of Vistagen Therapeutics' shares are currently sold short. Learn More on Vistagen Therapeutics' current short interest. What is a good short interest ratio for Vistagen Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTGN shares currently have a short interest ratio of 2.0. Learn More on Vistagen Therapeutics's short interest ratio. What is a good short interest percentage for Vistagen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.70% of Vistagen Therapeutics' floating shares are currently sold short. Is Vistagen Therapeutics' short interest increasing or decreasing? Vistagen Therapeutics saw a decrease in short interest in November. As of November 30th, there was short interest totaling 425,500 shares, a decrease of 0.5% from the previous total of 427,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vistagen Therapeutics' float size? Vistagen Therapeutics currently has issued a total of 27,843,000 shares. Some of Vistagen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vistagen Therapeutics currently has a public float of 25,020,000 shares. How does Vistagen Therapeutics' short interest compare to its competitors? 1.70% of Vistagen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vistagen Therapeutics: Eledon Pharmaceuticals, Inc. (1.15%), UroGen Pharma Ltd. (24.60%), Rezolute, Inc. (1.93%), Atea Pharmaceuticals, Inc. (3.52%), Chimerix, Inc. (0.81%), Atyr PHARMA INC (2.65%), Mersana Therapeutics, Inc. (7.08%), Heron Therapeutics, Inc. (18.11%), Fulcrum Therapeutics, Inc. (8.49%), Aurora Cannabis Inc. (8.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Vistagen Therapeutics stock? Short selling VTGN is an investing strategy that aims to generate trading profit from Vistagen Therapeutics as its price is falling. VTGN shares are trading up $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vistagen Therapeutics? A short squeeze for Vistagen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTGN, which in turn drives the price of the stock up even further. How often is Vistagen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTGN, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Eledon Pharmaceuticals Short Interest UroGen Pharma Short Interest Rezolute Short Interest Atea Pharmaceuticals Short Interest Chimerix Short Interest Atyr PHARMA Short Interest Mersana Therapeutics Short Interest Heron Therapeutics Short Interest Fulcrum Therapeutics Short Interest Aurora Cannabis Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vistagen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vistagen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTGN Stock Alerts